Combination of coumarin and doxorubicin induces drug-resistant acute myeloid leukemia cell death

BACKGROUND: Chemotherapy remains to be the method of choice used by clinicians to treat acute myeloid leukemia (AML) patients. However, the most common problem usually faced in the course of treatment is multidrug resistance (MDR). Nowadays, combination therapy involving natural products as adjuvant...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Abbas, Nouf S., Shaer, Nehad A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7988287/
https://www.ncbi.nlm.nih.gov/pubmed/33786386
http://dx.doi.org/10.1016/j.heliyon.2021.e06255

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7988287/
https://www.ncbi.nlm.nih.gov/pubmed/33786386
http://dx.doi.org/10.1016/j.heliyon.2021.e06255

Ejemplares similares